Targeted Therapy Technologies, LLC (3T Ophthalmics) Receives FDA Breakthrough Therapy Designation for Episcleral Topotecan for the Treatment of Retinoblastoma—a Pediatric Ocular Cancer

Irvine, California, 4th October 2021—Targeted Therapy Technologies, LLC (3T Ophthalmics) has been awarded Breakthrough Therapy Designation by the U.S. Food and Drug Administration for its lead anti- cancer drug product candidate, Episcleral Topotecan, for the treatment of pediatric Retinoblastoma. Breakthrough Therapy Designation requires that the …

Meet Christina Gonzalez

At age 23, Christina Gonzalez is reaching tens of thousands on her Instagram page https://www.instagram.com/gogoldforchildhoodcancer/ building awareness about Childhood Cancer!  With areas on her page dedicated to Pediatric Leukemia, Sarcoma, DIPG, and Retinoblastoma among others, Christina has found a unique way to not only build …

शेन की चमक कहानी

निदान: रेटिनोब्लास्टोमा शेन का जन्म 25 अक्टूबर, २००० को लॉस एंजिल्स, सीए में हुआ था ।   वह पांच सप्ताह पहले थे और पांच दिनों तक एनआईसीयू में रहे । जब उनके माता-पिता डॉन और जो शेन को घर ले आए तो उन्होंने देखा कि वह असहज दिखाई दिए । कई के बाद ...